Evidence map›Paper›PMID 38399431›Full record

ArticlePharmaceuticals (Basel, Switzerland)2024

Design, Synthesis and Biological Assessment of

Najla A Alshaye, Mohamed K Elgohary, Mahmoud S Elkotamy, Hatem A Abdel-Aziz

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Najla A AlshayeDepartment of Chemistry, College of Science, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.
Mohamed K ElgoharyPharmaceutical Chemistry Department, Faculty of Pharmacy, Egyptian-Russian University, Cairo 11829, Egypt.
Mahmoud S ElkotamyPharmaceutical Chemistry Department, Faculty of Pharmacy, Egyptian-Russian University, Cairo 11829, Egypt.ORCID 0000-0002-8449-1788
Hatem A Abdel-AzizApplied Organic Chemistry Department, National Research Center, Dokki, Cairo 12622, Egypt.
Egyptian Russian University · EGNational Research Centre · EGPrincess Nourah bint Abdulrahman University · SA

Funding

Princess Nourah bint Abdulrahman University PNURSP2024R403
6 · The paper itself

Abstract

Breast cancer is a serious threat to the health and lives of women. Two novel series of

Indexed as

ADMEapoptosiscell cycleimidazo[2,1-b]thiazoleisatinMCF-7 cell linemolecular dockingPCRVGEFR-2

Identifiers

PMID38399431
PMCPMC10892120
OpenAlexW4391614815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.